No definition available.
Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)
C3_RENAL_PELVIS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
405 |
4. Check minimum number of eventsNone |
405 |
5. Include endpointsNone |
405 |
6. Filter based on genotype QC (FinnGen only) |
405 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 405 | 107 | 298 |
| Unadjusted period prevalence (%) | 0.11 | 0.04 | 0.13 |
| Median age at first event (years) | 71.09 | 70.35 | 71.35 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 173
- Matched controls
- 1729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
209.7
156
*
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
189.0
145
*
UKC02
NOMESCO Finland
Cystoscopy
40.9
91.9
143
180
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
+∞
62.3
56
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
61.1
55
*
R31
ICD-10 Finland
Unspecified haematuria
20.3
60.1
102
114
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
55.2
50
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
52.9
48
*
130
Kela drug reimbursment
Malignant tumour
+∞
49.4
45
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
40.2
37
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
441.0
36.4
35
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
73.6
36.0
40
7
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
29.0
27
*
H02AB02
ATC
dexamethasone; systemic
165.8
27.5
28
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
26.8
25
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
303.8
26.5
26
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
41.5
25.3
31
9
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
+∞
24.6
23
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
22.4
21
*
B01AB10
ATC
tinzaparin; parenteral
15.9
21.9
36
28
A03FA01
ATC
metoclopramide; systemic, rectal
8.3
21.7
52
85
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
21.3
20
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
118.8
20.0
21
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
18.8
19.7
30
19
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
+∞
19.1
18
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
212.0
18.9
19
*
JN4AD
NOMESCO Finland
Body CT examination
14.3
18.7
32
27
JN4BD
NOMESCO Finland
Extensive body CT
12.2
18.4
34
34
UKB02
NOMESCO Finland
Retrograde ureteroscopy
23.3
18.4
26
13
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
18.0
17
*
Z51.5
ICD-10 Finland
Palliative care
14.9
18.0
30
24
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
13.7
17.9
31
27
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
187.3
16.8
17
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.9
15
*
B02AA02
ATC
tranexamic acid; systemic
7.7
15.0
36
57
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.8
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
14.8
59
175
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.7
13.8
42
92
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
13.7
13
*
7126
FHL
Nephroureterectomy
+∞
12.7
12
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
12.5
40
92
N02AA05
ATC
oxycodone; systemic
4.5
11.8
46
130
ZX136
NOMESCO Finland
Intravesicalis
+∞
11.6
11
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
11.6
11
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
11.6
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
11.6
11
*
KC1GB
NOMESCO Finland
Cystography with X-ray
+∞
11.6
11
*
8000/3-C65.9
ICD-O-3
Neoplasm, malignant of renal pelvis
+∞
11.6
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.6
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.6
11
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
128.2
11.6
12
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.9
11.4
52
170
U06
ICPC
Haematuria
15.3
11.3
18
13
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.2
11.2
27
43
8130/3-C65.9
ICD-O-3
Papillary urothelial carcinoma of renal pelvis
+∞
10.5
10
*
1891C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,MUU/TARK MÄÄR SYÖPÄ]
+∞
10.5
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
18.1
10.1
15
9
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.5
9
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
9.5
9
*
J01MA02
ATC
ciprofloxacin; systemic
2.8
9.5
87
460
B01AB05
ATC
enoxaparin; parenteral
2.9
8.9
66
302
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.9
8.7
16
16
KH1AD
NOMESCO Finland
CT of urinary organs
9.3
8.5
17
20
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
94.5
8.5
9
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.4
8
*
J01EA01
ATC
trimethoprim; systemic
3.0
8.1
54
228
WZC30
NOMESCO Finland
Teaching
5.1
8.1
25
55
A04AA01
ATC
ondansetron; systemic, rectal
16.0
7.8
12
8
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
47.1
7.8
9
*
WX402
NOMESCO Finland
General anaesthesia
4.3
7.5
28
75
WX725
NOMESCO Finland
Noninvasive ventilation
9.0
7.5
15
18
L02AE02
ATC
leuprorelin; implant, parenteral
83.5
7.5
8
*
WW500
NOMESCO Finland
Blood transfusion
11.6
7.4
13
12
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
7.3
7
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
7.3
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.1
7.3
17
26
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
21.1
7.2
10
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
7.1
28
79
1530
FHL
Urethrocystoscopy
8.1
7.1
15
20
N02AX02
ATC
tramadol; systemic, rectal
2.4
7.1
81
463
ZXC15
NOMESCO Finland
Use of photodynamic technique
41.7
6.8
8
*
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
41.7
6.8
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
6.7
19
38
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
72.4
6.5
7
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
U75
ICPC
Malignant neoplasm of kidney
+∞
6.3
6
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
6.3
6
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
6.2
28
89
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
6.1
44
194
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
249
1100
4.28
45.51
8.5
3.0
—
—
—
0
0
125
406
4.01
33.83
8.5
4.7
1.1
1.0
mmol/l
2.12
119
367
240
1201
3.45
32.91
5.6
3.7
—
—
—
0
0
191
841
3.41
32.15
9.1
2.8
0.3
0.5
e6/l
1.31
160
626
71
165
5.01
29.44
3.5
1.4
34.3
4.6
ug/l
0.50
59
130
92
277
4.00
27.22
9.5
6.1
11.9
11.6
mmol/l
0.10
82
259
305
1891
3.48
27.09
11.0
4.5
81.0
895.3
e6/l
—
5
40
147
618
3.16
25.69
2.9
2.1
—
—
—
0
0
231
1266
2.92
24.68
7.8
3.6
32.6
34.9
g/l
5.98
212
1155
245
1402
2.89
23.85
10.4
3.8
9.8
12.7
umol/l
4.61
240
1301
249
1477
2.78
21.94
11.0
5.5
1.2
1.2
mmol/l
1.07
212
1246
105
393
3.26
21.93
9.0
5.7
5.2
5.1
kpa
0.68
97
377
105
393
3.26
21.93
9.0
5.7
13.5
11.2
kpa
4.23
97
378
89
306
3.45
21.27
4.8
2.7
237.7
241.8
u/l
0.18
84
284
124
522
2.98
21.04
8.0
2.6
1.6
1.0
e6/l
0.70
95
299
118
492
2.97
20.29
8.5
2.8
1.0
2.1
e6/l
1.72
90
271
102
397
3.10
19.76
9.3
5.7
-1.1
1.5
mmol/l
6.68
78
295
230
1360
2.60
19.61
10.7
5.0
1.2
1.2
mmol/l
0.77
216
1197
271
1787
2.56
17.55
7.8
4.3
6.8
7.0
mmol/l
0.56
259
1668
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
105
4.58
17.41
4.0
2.5
0.4
0.4
u/ml
0.02
24
58
236
1479
2.43
16.81
14.4
5.5
4.8
4.5
e9/l
0.71
205
1276
31
59
5.61
15.86
4.3
1.8
93.0
134.4
u/ml
0.11
24
45
168
941
2.34
15.04
7.0
2.1
2.3
2.3
mmol/l
0.34
145
750
295
2151
2.37
13.38
13.2
5.2
92.6
78.1
u/l
3.45
285
1952
63
242
2.90
12.14
5.4
3.8
123.1
94.4
ng/l
1.28
52
205
75
334
2.53
10.79
6.9
3.2
5.9
5.8
kpa
0.19
68
323
44
154
3.08
9.95
8.6
3.4
24.2
24.3
mmol/l
0.08
38
138
73
333
2.45
9.94
7.1
3.2
1.8
2.2
mmol/l
0.32
51
275
107
580
2.15
9.68
5.2
2.2
2.5
2.4
mmol/l
5.18
92
479
204
1393
1.94
9.63
6.1
3.9
0.0
0.0
estimate
0.00
49
220
201
1371
1.93
9.47
7.3
5.2
0.0
0.0
estimate
0.00
49
219
198
1376
1.86
8.52
5.9
3.8
0.0
0.0
estimate
0.00
49
225
93
500
2.12
8.49
3.6
2.3
10.3
12.7
umol/l
2.88
87
455
85
450
2.13
8.05
3.7
2.3
2.1
2.2
g/l
1.59
78
413
11
6
18.79
7.64
1.6
1.0
—
—
—
0
0
80
424
2.11
7.52
4.1
2.4
19.7
23.2
%
1.61
68
364
11
7
16.10
7.26
1.8
2.4
8.2
5.2
nmol/l
—
11
7
39
153
2.71
7.18
2.3
1.8
1.8
1.5
g/l
0.92
32
130
109
668
1.86
6.70
5.3
4.1
103.2
323.7
ng/l
1.60
99
570
124
801
1.79
6.39
3.3
2.6
8703.9
11780.6
umol/l
0.20
105
664
127
835
1.76
6.12
2.3
2.1
3.0
3.1
mg/l
0.18
113
687
137
924
1.73
6.02
3.8
2.1
61.2
57.7
u/l
0.63
131
851
29
107
2.84
5.99
4.2
3.5
—
—
—
0
0
88
541
1.80
5.24
2.2
1.8
—
—
—
0
0
51
267
2.04
4.91
3.1
1.6
66.7
67.1
g/l
0.13
43
233
42
207
2.15
4.73
1.5
1.6
—
—
—
0
0
45
229
2.09
4.67
6.1
3.8
5.4
5.2
kpa
0.76
38
208
322
2806
1.72
4.64
30.6
14.6
39.5
27.0
mg/l
6.76
302
2204
66
391
1.82
4.41
2.1
1.8
—
—
—
0
0
52
285
1.95
4.41
4.2
2.7
5.2
4.5
kpa
0.56
46
271
16
50
3.29
4.38
1.1
1.2
—
—
—
0
0
11
26
4.32
4.38
2.7
1.5
—
—
—
0
0
41
209
2.07
4.24
1.7
1.5
—
—
—
0
0
18
62
2.99
4.22
1.1
1.4
—
—
—
0
0
42
217
2.04
4.20
3.2
2.1
44.9
57.0
ml/min/173m2
1.95
26
91
80
510
1.71
4.16
28.9
30.7
1.5
1.5
inr
0.01
13
60
17
59
2.96
3.95
1.1
1.4
—
—
—
0
0
64
390
1.76
3.89
2.2
1.8
—
—
—
0
0
281
2410
1.54
3.88
36.9
15.7
35.6
39.2
%
4.93
183
1444
40
216
1.95
3.55
6.5
3.9
2.3
2.1
mmol/l
0.07
28
159
141
1067
1.49
3.49
7.1
4.1
—
—
—
0
0
85
576
1.60
3.46
1.6
1.7
2.1
1.3
mg/l
1.45
73
451
13
42
3.16
3.40
1.2
1.2
—
—
—
0
0
106
759
1.54
3.40
7.5
4.1
0.0
0.0
estimate
0.00
39
210
247
2095
1.46
3.34
4.2
4.0
20.6
13.4
mm/h
5.49
219
1878
55
338
1.73
3.25
4.0
3.5
382.8
244.7
ng/l
0.87
48
315
12
38
3.22
3.24
1.2
1.2
—
—
—
0
0
197
1611
1.43
3.19
4.6
4.0
2.7
2.1
ug/l
0.81
157
1420
10
29
3.51
3.06
6.3
1.4
—
—
—
0
0
52
321
1.71
3.03
5.7
3.2
—
—
—
0
0
145
1129
1.44
3.03
3.9
2.7
259.4
159.8
ug/l
1.20
131
1005
132
1016
1.44
2.91
1.8
2.2
114.6
327.8
u/l
2.07
121
937
12
41
2.99
2.88
1.1
1.2
—
—
—
0
0
23
110
2.16
2.84
1.1
1.3
94.8
119.9
iu/ml
—
6
43
15
61
2.52
2.65
1.7
1.4
—
—
—
0
0
35
202
1.80
2.58
2.4
1.6
—
—
—
0
0
255
2233
1.38
2.53
41.4
16.9
14.4
13.8
%
10.86
248
2165
7
16
4.43
2.48
1.0
1.2
—
—
—
0
0
7
16
4.43
2.48
1.0
1.2
—
—
—
0
0
12
45
2.72
2.47
3.3
1.4
—
—
—
0
0
6
12
5.06
2.41
1.0
1.3
—
—
—
0
0
6
13
4.67
2.28
1.0
1.0
—
—
—
0
0
19
93
2.09
2.25
3.6
2.7
25.1
24.8
mmol/l
0.09
14
78
327
3015
1.44
2.20
39.7
18.0
138.8
139.8
mmol/l
7.09
320
2900
288
2601
1.37
2.18
32.7
13.5
56.5
72.5
ml/min/173m2
25.65
264
2095
18
88
2.09
2.14
1.1
1.6
—
—
—
0
0
8
25
3.24
2.10
1.3
1.4
—
—
—
0
0
327
3023
1.42
2.09
40.4
18.1
4.1
4.0
mmol/l
7.41
320
2908
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
11
44
2.54
2.03
1.0
1.4
—
—
—
0
0
6
16
3.79
1.94
1.2
1.3
—
—
—
0
0
321
2976
1.38
1.87
16.5
9.1
23.9
26.0
u/l
1.34
307
2813
134
1104
1.32
1.83
3.6
4.0
21.9
8.9
mg/mmol
1.88
89
709
110
885
1.33
1.77
3.2
2.8
1.0
0.8
ug/l
0.55
66
602
22
125
1.80
1.75
2.2
1.5
—
—
—
0
0
8
30
2.70
1.73
1.0
1.6
—
—
—
0
0
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
138
1152
1.30
1.70
3.2
3.2
3969.2
1865.7
ng/l
1.88
127
992
132
1096
1.30
1.69
2.1
2.2
77.8
77.8
nmol/l
0.00
114
920
7
25
2.83
1.65
1.0
1.3
—
—
—
0
0
162
1386
1.28
1.64
2.2
2.1
87.4
92.9
pmol/l
0.98
94
721
14
70
2.04
1.61
1.2
1.4
—
—
—
0
0
20
114
1.79
1.59
2.1
1.4
—
—
—
0
0
84
660
1.34
1.57
6.9
4.3
1.0
1.0
kg/l
0.15
16
103
5
15
3.36
1.53
2.6
3.5
—
—
—
0
0
7
27
2.62
1.52
1.0
1.3
—
—
—
0
0
6
21
2.88
1.51
2.0
1.5
1945.1
179.5
u/ml
—
6
21
12
58
2.10
1.50
1.3
1.6
—
—
—
0
0
327
3083
1.31
1.37
46.2
21.1
4.2
4.5
e12/l
16.71
317
2940
188
1666
1.24
1.35
3.4
3.0
68.9
53.4
u/l
0.80
175
1514
90
734
1.29
1.30
1.8
1.8
1022.7
1169.5
nmol/l
0.67
70
549
223
2024
1.23
1.24
4.4
3.4
15.0
15.1
pmol/l
0.24
195
1782
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
8
38
2.13
1.19
1.0
1.4
—
—
—
0
0
22
142
1.58
1.17
2.9
2.2
404.2
698.2
ug/l
0.35
22
131
8
39
2.07
1.16
2.3
1.4
—
—
—
0
0
21
135
1.59
1.14
3.0
1.3
4.2
3.9
g/l
0.71
16
88
21
135
1.59
1.14
3.0
1.3
7.7
7.7
g/l
0.00
16
92
21
135
1.59
1.14
3.0
1.3
—
—
—
0
0
148
1299
1.22
1.12
4.4
3.9
22.5
24.8
%
1.11
74
646
36
484
0.72
1.09
1.1
1.2
0.6
1.8
u/ml
—
6
123
8
41
1.97
1.09
3.8
3.6
—
—
—
0
0
5
22
2.29
1.03
1.2
2.6
—
—
—
0
0
7
35
2.02
1.00
1.4
1.2
—
—
—
0
0
151
1341
1.20
1.00
4.5
4.3
45.9
72.0
ng/l
0.47
123
1041
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
16
100
1.62
0.98
1.6
1.6
—
216.7
—
0
6
7
36
1.96
0.97
1.4
1.1
—
—
—
0
0
7
36
1.96
0.97
1.1
1.4
0.7
0.6
nmol/l
—
7
31
12
71
1.71
0.89
4.1
1.9
17.3
15.7
%
—
5
35
8
137
0.58
0.85
2.3
1.8
—
—
—
0
0
28
371
0.74
0.81
1.2
1.3
20.4
12.1
u/ml
0.18
11
123
31
401
0.75
0.77
1.2
1.3
13.9
40.8
iu/ml
—
10
124
15
99
1.53
0.76
1.1
1.3
—
—
—
0
0
5
24
2.10
0.74
1.8
1.1
—
—
—
0
0
9
55
1.65
0.74
1.1
1.2
—
—
—
0
0
5
25
2.01
0.73
1.0
1.5
—
—
—
0
0
13
84
1.57
0.72
1.4
1.3
—
—
—
0
0
64
751
0.82
0.71
1.6
1.7
1.4
1.3
mmol/l
0.73
53
599
0
20
0.00
0.60
0.0
1.1
—
1.2
—
0
11
42
354
1.21
0.50
2.6
2.8
3.3
7.4
ug/l
3.43
36
304
256
2657
0.90
0.44
4.0
4.4
1.4
1.3
mmol/l
1.00
223
2357
138
1287
1.11
0.43
2.5
2.3
—
—
—
0
0
264
2544
1.11
0.43
5.5
4.3
2.0
2.0
mu/l
0.15
237
2240
6
92
0.65
0.43
1.5
1.8
44.0
42.9
nmol/l
—
6
85
5
32
1.57
0.42
1.2
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
8
0
16
0.00
0.41
0.0
1.3
—
201.8
—
0
16
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
11
82
1.35
0.34
1.3
1.5
—
—
—
0
0
267
2741
0.92
0.29
4.3
4.9
1.3
1.4
mmol/l
2.01
236
2454
270
2770
0.92
0.29
4.4
4.9
4.2
4.3
mmol/l
1.73
237
2504
17
140
1.22
0.28
1.3
1.3
—
—
—
0
0
28
243
1.16
0.27
1.0
1.3
—
—
—
0
0
36
403
0.88
0.26
4.2
5.1
34.2
33.1
%
0.20
21
264
9
72
1.26
0.26
1.4
1.4
—
—
—
0
0
9
72
1.26
0.26
1.4
1.4
—
—
—
0
0
9
73
1.24
0.25
1.2
1.5
—
—
—
0
0
18
151
1.20
0.25
1.4
1.4
—
50.3
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
8
103
0.77
0.21
1.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
24.6
—
0
8
0
14
0.00
0.20
0.0
1.4
—
19.0
—
0
6
80
760
1.07
0.17
1.6
1.8
388.9
9344679.6
pmol/l
0.50
62
610
5
67
0.74
0.17
1.8
2.0
177.4
222.5
pmol/l
—
5
62
6
79
0.76
0.15
1.0
1.2
—
—
—
0
0
6
79
0.76
0.15
1.0
1.2
—
—
—
0
0
90
866
1.05
0.13
1.6
1.6
16.7
20.3
nmol/l
1.94
80
722
269
2722
0.96
0.10
7.2
6.8
41.3
41.6
mmol/mol
0.16
238
2475
39
411
0.94
0.09
12.2
8.6
—
—
—
0
0
8
94
0.85
0.06
1.0
1.0
—
—
—
0
0
283
2849
0.98
0.05
4.9
5.5
2.3
2.5
mmol/l
3.38
241
2554
12
129
0.93
0.03
1.4
1.2
199.6
220.7
u/ml
0.09
12
116
281
2816
0.99
0.00
5.3
5.0
6.1
6.2
mmol/l
0.49
245
2488
7
77
0.91
0.00
1.6
1.6
55861.1
16128.3
e6/l
—
7
59
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
10.0
—
0
7
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
1.3
—
0
6
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
7
75
0.93
0.00
1.4
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
2092.7
—
0
6
5
56
0.89
0.00
1.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RENAL_PELVIS_EXALLC – Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).